In a previous paper1 an attempt was made to show, by means of experimental data that the intraperitoneal transfusion of freshly citrated blood is a method of distinct value. It was found that it was a safe procedure, simple in its application and clinically effective. It was proposed as a therapeutic procedure of merit in selected cases. It is the purpose of the present paper to report in some detail five cases in which the intraperitoneal route for blood transfusion was utilized.
REVIEW OF LITERATURE
The intraperitoneal injection of defibrinated blood was first used clinically by Ponfick2 in 1875. Isolated cases have been reported by Golgi and Raggi,3 Magniagalli,4 Scottini,5 Giovanni,6 von Kaczorowski,7 Liegl8 and Burresi.9Careful observations and laboratory data were not given in any of the cases cited. In all instances, defibrinated blood was used. The results obtained were
SIPERSTEIN DM. INTRAPERITONEAL TRANSFUSION WITH CITRATED BLOOD: A CLINICAL STUDY. Am J Dis Child. 1923;25(3):202–221. doi:10.1001/archpedi.1923.01920030019003
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.